To determine mechanisms of neonatal parasite antigen (Ag)-specific immune suppression associated with placental Plasmodium falciparum infection, we isolated cord blood mononuclear cells (CBMCs) from Gabonese neonates born to mothers with differing histories of P. falciparum infection and performed ex vivo and in vitro studies to evaluate immune regulatory activity. We found increased ex vivo percentages of CD4 + CD25 hi and CD4 + CD25 +
CTLA-4 + cells and increased interleukin (IL)-10 responses to parasite Ag in vitro in CBMCs from neonates born to mothers with placental P. falciparum infection at delivery. Depleting CBMCs of CD4 +

CD25
+ cells before cell culture led to the abrogation of parasite Ag-specific IL-10 responses, to enhanced interferon-g responses, and to enhanced expression of CD25 on CD8 + T cells and of major histocompatibility complex class I and II on monocytes. These data demonstrate that parasite Ag-specific CD4 + regulatory cells are generated in utero as a consequence of placental P. falciparum infection.
The impact of placental Plasmodium falciparum infection on the immune competence of the neonate remains poorly understood. Congenital malaria infections are rare, but children born to mothers with placental P. falciparum infection at delivery are more susceptible than other children to infection and/or malaria [1, 2] . These observations are strongly suggestive of some form of immune modulation occurring in utero-a process that the results of other studies have indicated arises as a consequence of the transplacental transfer of soluble P. falciparum antigen (Ag) [3] [4] [5] [6] . We previously demonstrated that, in neonates born to mothers with placental P. falciparum infection, P. falciparum Ag-specific immune responses from cord blood mononuclear cells (CBMCs), including the production of interferon (IFN)-g by T cells, are markedly enhanced in the presence of neutralizing anti-interleukin (IL)-10 antibody [7] . We hypothesize that exposure of the fetal immune system to P. falciparum Ag induces the generation of both effector and regulatory/suppressor T cells.
It has been proposed that Ag-induced regulatory T cells (a subset of IL-10-dependent, IL-4-independent, Ag-specific regulatory T cells), which are otherwise known as Tr1 cells, are generated during priming in the presence of IL-10 and/or immature dendritic cells (DCs) [8] [9] [10] [11] , 2 conditions that prevail during fetal immune development. Neonatal DCs represent immature forms of Ag-presenting cells, because they express low levels of costimulatory molecules and Th1-inducing cytokines when they encounter Ags [12, 13] . IL-10 levels are enhanced in the fetal circulation [14] , presumably to con- trol the pathological effects of inflammation. The cogeneration of effector T cells and regulatory T cells has been documented in various human infections, particularly chronic infection [15] [16] [17] [18] . We asked whether placental P. falciparum infection, which exposes the fetus to potentially chronic and high levels of soluble parasite Ag during gestation, induces the generation of activated regulatory T cell populations. To this end, we examined CBMCs from neonates born to mothers with differing histories of malaria living in a region of Gabon where malaria is endemic. Experiments conducted both ex vivo and in vitro demonstrated that placental P. falciparum infection is associated with enhanced regulatory CD4 + cell activity that suppresses both effector T cell responses and major histocompatibility complex (MHC) class I and II expression on monocytes.
SUBJECTS, MATERIALS, AND METHODS
Study population.
The study was performed at the Albert Schweitzer Hospital in Lambaréné, Gabon (a site with perennial transmission of P. falciparum; entomological inoculation rate, 50) [19] , from May to December 2003, and informed consent for participation was obtained before subjects were included in the study. Venous umbilical cord blood from 54 neonates was obtained immediately after birth. The collection of cord blood involved direct aspiration via puncture of the ethanol-sterilized umbilical vein at a site distal to the placenta, to reduce to a minimum the possibility of cross-contamination by maternal lymphocytes. The presence of P. falciparum in cord blood, placental blood, and maternal venous blood was determined by microscopic examination of Giemsa-stained thick and thin smears. The mothers' medical records were examined to identify those who had received a diagnosis of and been treated for malaria during pregnancy. Most women who had malaria during pregnancy had been treated with quinine, which has been reported to retain 100% efficacy for the treatment of uncomplicated P. falciparum malaria arising during pregnancy in the study area [20] . For comparative analyses, the following distinct groups were thus defined on the basis of the presence or absence of placental P. falciparum infection by blood smear and of assessment of documented medical history: (1) negative, no evidence of P. falciparum parasites in the placental and maternal venous blood at delivery and no record of maternal malaria during pregnancy; (2) placenta positive, P. falciparum asexualstage parasites present in the placental blood; and (3) treated, no evidence of P. falciparum parasites in the placental and maternal venous blood at delivery but a recorded history of a diagnosed and treated maternal episode of malaria during pregnancy, at least 2 weeks before delivery. None of the cord blood samples in the study had detectable levels of parasitemia. Table  1 provides a summary of the study population. Ethical clearance for the study was given by the ethics committee of the International Foundation of the Albert Schweitzer Hospital in Lambaréné.
Blood-stage parasite Ag (pRBC lysate) preparation. pRBC lysate was prepared from schizont-infected erythrocytes using a local P. falciparum isolate cultured and synchronized by temperature cycling through 37ЊC, 40ЊC, and 17ЊC. Schizontinfected erythrocytes or uninfected erythrocytes (RBC lysate) were Percoll purified, resuspended in RPMI 1640, and frozen and thawed 1 time before addition to the culture.
Isolation of CBMCs and cell culture. CBMCs were isolated by standard density-gradient centrifugation at 800 g on FicollPaque (Amersham). For ex vivo surface-marker analysis, cells were immediately resuspended in 2% paraformaldehyde/PBS and stored at 4ЊC. For in vitro studies, cells were immediately resuspended at cells/mL in complete medium, and 0.5 6 5 ϫ 10 mg/mL of both anti-human-CD28 and -CD49d antibodies (BD Biosciences) was added for the acquisition of optimal T cell responses [21] . Complete medium was composed of RPMI 1640 medium (Sigma) supplemented with 10% (wt/vol) human serum (AB; Sigma), 1 mmol/L l-alanylglutamine (Life Technologies), 100 U/mL penicillin, 100 mg/mL streptomycin (Life Technologies), and 1 mmol/L sodium pyruvate (Life Technologies). Antibodies specific for human CD3 (HIT3a, 10 mg/mL; BD Biosciences), uninfected red blood cells (uRBC lysate), or pRBC lysate (1 CBMC:10 RBCs) were added to the cells, followed by incubation at 37ЊC in a humidified 5% CO 2 atmosphere. For analysis of cytokines in culture supernatants, cells were incubated for 48 h, and harvested supernatants were stored at Ϫ80ЊC. For intracellular cytokine analysis, 10 mg/mL brefeldin A (Sigma) was added after 18 h of culture, and the cells were incubated for an additional 4 h before fixation. Cells were washed in PBS, fixed with 2% formaldehyde for 20 min, resuspended in Hanks' balanced salt solution/0.1% azide/0.1% bovine serum albumin (BSA), and stored at 4ЊC before staining for flowcytometric analysis.
For CD4 + CD25 + depletion studies, CBMCs were 6 35 ϫ 10 resuspended in MACS buffer (PBS, 2 mmol/L EDTA, and 0.5% + cells among neonates were segregated according to maternal P. falciparum infection history. Box plots illustrate medians with 25th and 75th percentiles and whiskers for 10th and 90th percentiles. * , Mann-
human serum albumin or BSA). CD4 + cells were collected using anti-CD4 microbeads and a Mini-MACS magnetic separation column (Miltenyi Biotec), in accordance with the manufacturer's instructions, followed by enzymatic cleavage and removal of the anti-CD4 microbeads. The washed CD4 + cell population was then fractionated into CD25 + and CD25 Ϫ subsets using anti-CD25 microbeads (Miltenyi Biotec 6 .9%)-a difference that was not statistically significant ( , Mann-Whitney U test). P p .5 Measurement of cytokine production by ELISA and of intracellular cytokine production and surface markers by flowcytometric analysis. ELISA was used in accordance with the manufacturer's recommendations (Biosource) for the detection of IL-2, IL-10, and IFN-g in 48-h culture supernatants. For intracellular cytokine and cell surface marker analyses, cells were incubated on ice for 15 min with PBS/10% fetal calf serum (FCS) that contained 2 mL of FcR Blocking Reagent (Miltenyi Biotec), followed by staining with the following panel of fluorescently labeled antibodies (all supplied by BD Biosciences) (clone): CD3 (UCHT1), CD4 (SK3), CD8 (RPA-T8), CD25 (M-A251), CTLA-4 (BNI3), CD14 (M5E2), HLA-A,B,C (G46-2.6), and HLA-DR (L243); or isotype control antibodies mouse IgG1 conjugated to fluorescein isothiocyanate (FITC), phycoerythrin (PE), peridinin-chlorophyll-protein (PerCP), or allophycocyanin (MOPC-21) and mouse IgG2a conjugated to FITC, PE, or PerCP (G155-178). For the intracellular staining of IFNg and IL-10, the Cytofix/Cytoperm Plus kit (BD Biosciences) was used in accordance with the manufacturer's protocol with the antibodies IFN-g-FITC (25723.11) or IL-10-PE (JES3-9D7) or the isotype control antibodies mouse IgG1-PE (MOPC-21) and mouse IgG2b-FITC (27) (28) (29) (30) (31) (32) (33) (34) (35) . Flow-cytometric analysis was performed on a FACScan flow cytometer with CellQuest data analysis software (version 3.3; BD Biosciences). A mean of ∼150,000 viable cells was gated.
Statistical analyses. The significance of differences between continuous variables was assessed using the Kruskal-Wallis test. If the Kruskal-Wallis test gave , the Mann-Whitney U (2 P ! .05 group) test was performed with the level of statistical significance in all cases set at . P ! .05
RESULTS
Placental P. falciparum infection and increased frequencies of CD4
+ cells expressing CD25 and CTLA-4 in cord blood. We wished to determine whether placental P. falciparum infection induces T cell activation in utero. The presence of CD25 and CTLA-4 on T cells is generally associated with the extent of activation of both effector and regulatory T cells [10, [22] [23] [24] . We compared the percentages of CD4 + cells expressing CD25, CD25 hi , and CTLA-4 in freshly isolated CBMCs from the 3 groups of neonates described in Subjects, Materials, and Methods: negative ( ), placenta positive ( ), and treatn p 20 n p 20 ed (
). Representative flow-cytometric analysis data (exn p 14 pressed as dot plots in figure 1A) figure 1C ) or coexpressing CD25 and CTLA-4 ( figure 1D ) than did CBMCs from negative neonates. The percentages of CD4 + cells expressing CD25 or CD25 hi in CBMCs from treated neonates were higher than those of negative neonates, although these differences were not statistically significant ( figure 1B and 1C) .
Production of IL-10 by cord blood CD4 + cell subsets in response to P. falciparum Ag. In an earlier study, we found that neutralizing anti-IL-10 antibody increased P. falciparum Ag-specific IFN-g responses from cord blood T cells [7] . In the present study, we detected elevated concentrations of IL-10 in the culture supernatants of P. falciparum Ag-stimulated CBMCs from placenta-positive neonates, compared with those from negative and treated neonates (figure 2A). Nonspecific stimulation induced significantly higher IL-10 production by CBMCs from both placenta-positive and treated neonates, compared with those from negative neonates (figure 2B). To clarify the source of IL-10 in CBMC samples, we performed flowcytometric analysis with gating on CD4 + cells and segregated P. falciparum Ag-specific IL-10 + cell populations expressing CD25 and CTLA-4. We identified CD4 + CD25
+ cells in placenta-positive CBMCs as the population with the highest median percentage of P. falciparum Ag-specific IL-10 + cells ( figure 2C ). Nonspecific stimulation of CBMCs with anti-CD3 plus anti-CD28 antibody revealed a similar profile ( figure 2D ). Figure  2E shows a representative flow-cytometric analysis dot plot of IL-10 production from uRBC lysate-stimulated, pRBC lysatestimulated, and anti-CD3 plus anti-CD28 antibody-stimulated CD4 + cells that were gated on CD25 + (upper panels) and CD25 Depletion of CD4 + CD25 + cells from freshly isolated CBMCs: in vitro reduction in IL-10 production and increase in IFN-g production. Given that CBMCs from placenta-positive neonates contained increased percentages of CD4 + CD25
+ cells, a proportion of which produced IL-10 in response to P. falciparum Ag, we explored the effect of their depletion on P. falciparum Ag-specific IL-10 and IFN-g production. The depletion of CD4 + CD25 + cells before CBMC culture significantly reduced the concentration of IL-10 in culture supernatants that was detectable after stimulation with P. falciparum Ag ( figure  3A) and also reduced the median percentage of P. falciparum Ag-specific IL-10 + cells before culture significantly increased the median concentrations of P. falciparum Ag-specific IFN-g in culture supernatants from both placenta-positive and treated neonates ( figure 3C) T cells ( figure 3D ), although these differences were not of statistical significance. These data clearly imply the existence, within CBMCs from neonates presumed to have been sensitized as a result of maternal P. falciparum infection, of a population of in utero-induced P. falciparum Ag-specific IL-10 + cells. Given that CD25 expression is regulated by IL-2, we measured the concentration of anti-CD3 plus anti-CD28 antibody-driven IL-2 in CBMC culture supernatants and found that those from placenta-positive neonates contained significantly less IL-2 than that found in supernatants from treated neonates (figure 4C). Little P. falciparum Ag-specific IL-2 was detected in the culture supernatants from any of the samples (data not shown). CD4 + CD25 + cell suppression of MHC class I and II expression on monocytes during stimulation with P. falciparum Ag. Both IL-10 and CD4 + CD25 + regulatory cells have been shown to suppress the expression of costimulatory molecules on DCs and monocytes, which impairs their function and their ability to activate T cells [25] [26] [27] . Similar to observations that we have previously reported [7] , MHC class I and II expression on monocytes was reduced in response to stimulation with pRBC lysate relative to that in uRBC lysate-stimulated cultures (100 ϫ pRBC mean fluorescence intensity MFI/ [MFI] Ϫ uRBC uRBC MFI) in CBMCs from placenta-positive neonates ( figure  5A ). The depletion of CD4 + CD25
+ cells before CBMC coculture with pRBC lysate led to significantly increased levels of MHC class I and II on monocytes from placenta-positive neonates, although not on monocytes from negative and treated neonates 
DISCUSSION
We present evidence that a subset of CD4 + cells suppress P. falciparum Ag-specific Th1 and CD8 + T cell IFN-g responses and MHC class I and II expression on CBMCs from neonates who were exposed to P. falciparum Ag as a result of placental P. falciparum infection. Immune suppression was associated with IL-10 production and was dependent on the presence of CD4 + CD25 + cells during in vitro culture. The role and effectiveness of CD8 + T cells on asexual blood-stage parasites is likely to be limited, compared with that of CD4 + cells, but it has been speculated that they may contribute to parasite clearance through IFN-g production [28] . We found that CD8 + T cell responses-both IFN-g production and CD25 surface expression-were enhanced in the absence of CD4 responses by inhibiting the up-regulation of CD25 and IL-2 production [29] . There was significantly less anti-CD3 plus anti-CD28-driven IL-2 detected in CBMC culture superna- tants from placenta-positive neonates, compared with those from treated neonates, although we did not determine whether CD8 + T cell IL-2 production was specifically inhibited, nor was it determined whether IL-2 was being produced but quickly consumed from the supernatants in this group.
Under normal culture conditions, P. falciparum Ag-specific IFN-g responses were highest in CBMCs from treated neonates. Although IFN-g responses were highest in treated neonates, we also found evidence of CD4 + CD25
+ cell-mediated suppression of these responses. The results from treated neonates were less homogeneous than were those observed in placenta-positive neonates. We postulate that the duration and intensity of placental infection in treated neonates-variables that are impossible to measure before delivery-are likely to have been associated with effector and regulatory T cell activity. Ag-induced regulatory T cells require the presence of chronic low levels of Ag and have a relatively limited effect in the absence of persistent Ag [30] . The homogeneous and relatively reduced profile of cytokine responses observed in CBMCs from negative neonates is a good indication that parasitemia below the limit of detection of blood-smear analysis is too low to induce immune sensitization in the fetus. It should be noted that CBMCs from treated neonates, like those from placenta-positive neonates, contained elevated percentages of CD4 + cells expressing CD25 hi that may also have imposed regulatory activity in an IL-10-independent manner [31] , although perhaps not as strongly as activated IL-10 + regulatory cells isolated from placenta-positive neonates.
To date, the identification of both natural and Ag-induced CD4 + regulatory cells by surface phenotyping has relied, in part, on the presence of CD25 and CTLA-4, because regulatory cells are enriched in this population. Thymic-derived CD4 + CD25 + regulatory cell activity is associated with expression of the transcription factor Scurfin, which is encoded by the forkhead/ winged helix (foxp3) gene [32, 33] . We measured foxp3 gene expression using real-time polymerase chain reaction with mRNA purified from freshly isolated CBMCs from 15 neonates and found similar levels of foxp3 mRNA among the 3 groups (relative to the ribosomal 18s RNA gene) (data not shown). Furthermore, foxp3 expression was up-regulated in some CBMCs in response to culture with pRBC lysate, irrespective of maternal P. falciparum infection history. Other researchers have also reported a disassociation between foxp3 expression and Aginduced regulatory T cell activity [22, 34] . The current capacity to differentiate thymic-derived from Ag-induced regulatory T cells in humans is limited. It has been proposed that the expression of CD25 hi by CD4 + cells distinguishes thymic-derived regulatory T cells [35] ; however, we observed a higher percentage of circulating CD4 + CD25
hi cells in cord blood samples from neonates born to P. falciparum-infected mothers, compared with those born to uninfected mothers. Cancer patients with advanced disease have a significantly higher percentage of CD4 + CD25 hi cells in their lymph nodes than did patients with early or no disease [36] . These observations suggest that CD4 + CD25
hi cells expand in the periphery during the course of infection or disease progression. The separation of CD25 lo -and CD25 hi -expressing CD4 + cells using flow-cytometric analysis rather than by magnetic bead-based methods would provide more-detailed information on the precise cell subset that is responsible for the Ag-driven suppressive effects that we observed. Although our data showed that the presence of IL-10 and CD4 + CD25
+ cells induced a degree of suppression on T cell IFN-g responses and MHC expression on monocytes in response to P. falciparum Ag, we did not exclude the contribution of other regulatory cells-such as thymic-derived
CD4
+ CD25 + regulatory cells [37] , CD8 + T cells [38] , or cytokines such as transforming growth factor-b [39] -in controlling inflammatory responses to P. falciparum Ag.
In conclusion, we provide evidence that cord blood from neonates whose mothers were infected with P. falciparum during pregnancy contains an expanded population of Ag-specific IL-10 +
+ CD25 + CTLA-4 + regulatory cells that suppress in vitro P. falciparum Ag-specific Th1-type and CD8 + T cell IFN-g responses and that down-regulate MHC expression on monocytes. Thus, although potentially protective P. falciparum-specific immune responses are initially induced in the fetus, these responses can be restricted by regulatory T cell activity. If so, controlling the induction of regulatory T cell responses may increase beneficial effector T cell responses against P. falciparum infection that would reduce parasitemia and associated illness in children at risk of infection early in life.
